Archynetys Live news trend intelligence
◼ Archived Business 🔮 Archynetys predicts: still trending tomorrow — graded ✗ wrong

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Germany's Merck KGaA is acquiring Minneapolis-based Bio-Techne in an $11.3 billion all-cash deal to expand its life sciences reach.

15sources
17articles
16velocity
+0%since first seen
20d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

Merck KGaA, Darmstadt, Germany, agreed to acquire Bio-Techne in an $11.3 billion deal. The acquisition aimed to strengthen Merck's leadership position in the life sciences markets.

Epilogue added 17d ago, after coverage quieted.

The brief

Merck KGaA, Darmstadt, Germany, has agreed to purchase Bio-Techne for $11.3 billion. This all-cash acquisition aims to strengthen Merck's position in the life sciences market and boost its lab-tools business. Bio-Techne is a Minneapolis firm providing approximately 500,000 products.

Coverage from Reuters, CNBC, and the Financial Times emphasizes that this is Merck's largest deal since the 2015 Sigma-Aldrich acquisition. Yahoo Finance reports that Bio-Techne's stock soared 20% following the news, while the Star Tribune notes it as one of the largest deals in Minnesota's history. Attention now turns to the realization of €140 million in synergies by year three.

Additionally, Deutsche Bank has adjusted Bio-Techne's price target to $73 from $66 while downgrading the stock to Hold from Buy.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 18d ago.

Quick answers

What is the total value of the acquisition?

The deal is valued at $11.3 billion.

How does this deal compare to Merck's previous acquisitions?

According to Fierce Pharma, it is Merck's biggest deal since the Sigma-Aldrich buy in 2015.

What are the projected synergies for the deal?

The acquisition is expected to yield €140 million in synergies by year three.

Coverage (17)

Topics

Merck KGaA Bio-Techne Life Sciences M&A Minneapolis

Related trends

◼ Archived Technology 🔮 fades ✓

It’s The Perfect Time To Watch GDQ

Summer Games Done Quick 2026 has concluded its charity marathon, raising $1.3 million through a series of high-profile speedruns.

5 sources 7 articles v 4 4d ago
◼ Archived Business 🔮 fades ✓

Blockbuster AI Deal Shows Why Honeywell Had to Break Up

Solstice Advanced Materials, a Honeywell spin-off, is pursuing a multi-billion dollar acquisition of Element Solutions to capitalize on the AI boom.

7 sources 8 articles v 5 8d ago